Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2018

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2018

  • Global Markets Direct
  • June 2018
  • Pharmaceutical
  • 1458 pages
Table of Contents
Table of Contents 2
Introduction 9
Multiple Myeloma (Kahler Disease) - Overview 10
Multiple Myeloma (Kahler Disease) - Therapeutics Development 11
Multiple Myeloma (Kahler Disease) - Therapeutics Assessment 62
Multiple Myeloma (Kahler Disease) - Companies Involved in Therapeutics Development 86
Multiple Myeloma (Kahler Disease) - Drug Profiles 164
Multiple Myeloma (Kahler Disease) - Dormant Projects 1378
Multiple Myeloma (Kahler Disease) - Discontinued Products 1398
Multiple Myeloma (Kahler Disease) - Product Development Milestones 1402
Appendix 1419

List of Tables
Number of Products under Development for Multiple Myeloma (Kahler Disease), H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Products under Development by Companies, H1 2018
Products under Development by Universities/Institutes, H1 2018
Number of Products by Stage and Target, H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018
Number of Products by Stage and Route of Administration, H1 2018
Number of Products by Stage and Molecule Type, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by 4SC AG, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by AbbVie Inc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Abpro, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Acceleron Pharma Inc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Actinium Pharmaceuticals Inc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Active Biotech AB, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Aduro BioTech Inc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Aeglea BioTherapeutics Inc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Affimed GmbH, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by AIMM Therapeutics BV, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Alissa Pharma, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Altor BioScience Corp, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Amgen Inc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Anthera Pharmaceuticals Inc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by APIM Therapeutics AS, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Array BioPharma Inc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Asana BioSciences LLC, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Ascentage Pharma Group Corp Ltd, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Aslan Pharmaceuticals Pte Ltd, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by AstraZeneca Plc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Atara Biotherapeutics Inc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Aurigene Discovery Technologies Ltd, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Autolus Ltd, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Bayer AG, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Bellicum Pharmaceuticals Inc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by BeyondSpring Pharmaceuticals Inc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by BioClin Therapeutics Inc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by BioLineRx Ltd, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Biomunex Pharmaceuticals, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Biotest AG, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by bluebird bio Inc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Boehringer Ingelheim GmbH, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Boston Biomedical Inc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Bristol-Myers Squibb Co, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Calithera Biosciences Inc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by CanBas Co Ltd, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by CARsgen Therapeutics Ltd, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Celgene Corp, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Cell Source Inc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Cellectar Biosciences Inc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Cellectis SA, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Cellerant Therapeutics Inc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Celleron Therapeutics Ltd, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Cellestia Biotech AG, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by CellProtect Nordic Pharmaceuticals AB, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Cellular Biomedicine Group Inc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Celyad SA, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Chong Kun Dang Pharmaceutical Corp, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by CRISPR Therapeutics, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Curis Inc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Cyclacel Pharmaceuticals Inc, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Daiichi Sankyo Co Ltd, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by DC Prime BV, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Dexcel PT Israel Ltd, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Eli Lilly and Co, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Enceladus Pharmaceuticals BV, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by eTheRNA Immunotherapies NV, H1 2018
Multiple Myeloma (Kahler Disease) - Pipeline by Exelixis Inc, H1 2018

List of Figures
Number of Products under Development for Multiple Myeloma (Kahler Disease), H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Number of Products by Top 10 Targets, H1 2018
Number of Products by Stage and Top 10 Targets, H1 2018
Number of Products by Top 10 Mechanism of Actions, H1 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018
Number of Products by Routes of Administration, H1 2018
Number of Products by Stage and Routes of Administration, H1 2018
Number of Products by Top 10 Molecule Types, H1 2018
Number of Products by Stage and Top 10 Molecule Types, H1 2018

Have query on this report?

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074